Direct Oral Anticoagulants in Antiphospholipid Syndrome: Too Early or Too Late?
- PMID: 31610546
- DOI: 10.7326/M19-2815
Direct Oral Anticoagulants in Antiphospholipid Syndrome: Too Early or Too Late?
Comment on
-
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.Ann Intern Med. 2019 Nov 19;171(10):685-694. doi: 10.7326/M19-0291. Epub 2019 Oct 15. Ann Intern Med. 2019. PMID: 31610549 Clinical Trial.
Similar articles
-
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.Lupus. 2016 Mar;25(3):301-6. doi: 10.1177/0961203315611495. Epub 2015 Oct 13. Lupus. 2016. PMID: 26466613 Clinical Trial.
-
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.Curr Rheumatol Rep. 2016 Dec;18(12):74. doi: 10.1007/s11926-016-0623-7. Curr Rheumatol Rep. 2016. PMID: 27812956 Review.
-
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome.Ann Intern Med. 2020 Apr 7;172(7):509-510. doi: 10.7326/L20-0052. Ann Intern Med. 2020. PMID: 32252074 No abstract available.
-
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Comment.Curr Rheumatol Rep. 2017 Aug;19(8):50. doi: 10.1007/s11926-017-0675-3. Curr Rheumatol Rep. 2017. PMID: 28730526 Free PMC article. Review.
-
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome.Ann Intern Med. 2020 Apr 7;172(7):510. doi: 10.7326/L20-0053. Ann Intern Med. 2020. PMID: 32252075 No abstract available.
Cited by
-
Bilateral adrenal haemorrhage secondary to rivaroxaban in a patient with antiphospholipid syndrome.BMJ Case Rep. 2020 Jul 1;13(7):e234947. doi: 10.1136/bcr-2020-234947. BMJ Case Rep. 2020. PMID: 32611655 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources